Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Blumenfeld Kan
HDL-cholesterol Elevation Associated With Fingolimod and Dimethyl Fumarate Therapies in Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Related publications
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Comparison of Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two-Year Experience
Multiple Sclerosis Journal – Experimental, Translational and Clinical
Dimethyl Fumarate for Relapsingremitting Multiple Sclerosis
Prescriber
Pharmacology
Nonfatal PML in a Patient With Multiple Sclerosis Treated With Dimethyl Fumarate
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Dimethyl Fumarate Treatment Alters NK Cell Function in Multiple Sclerosis
European Journal of Immunology
Allergy
Immunology
Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis
Frontiers in Immunology
Allergy
Immunology
Dimethyl Fumarate in the Management of Multiple Sclerosis: Appropriate Patient Selection and Special Considerations
Therapeutics and Clinical Risk Management
B-Cell Composition in the Blood and Cerebrospinal Fluid of Multiple Sclerosis Patients Treated With Dimethyl Fumarate
Multiple Sclerosis and Related Disorders
Medicine
Neurology
Nd3 - Meta-Analysis of Real-World Adherence and Persistence of Maintenance Once- Or Twice-Daily Oral Disease-Modifying Drugs (Dimethyl Fumarate, Fingolimod, and Teriflunomide) in Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
